Hair Loss at Injection Sites of Mesotherapy for Alopecia

    February 2017 in “ Journal of Cosmetic Dermatology ”
    Mohamed H.M. El-Komy, Akmal S. Hassan, Amira El Tawdy, Mohamed Solimon, Mohamed Abdel Hady
    Image of study
    TLDR Mesotherapy for hair loss can sometimes cause more hair loss and scarring.
    The study reported three cases of patients who developed patchy hair loss at the sites of mesotherapy injections for androgenetic alopecia. Mesotherapy is a minimally invasive procedure involving intradermal injections of various substances for medical or cosmetic purposes. The patients, all women with different grades of androgenetic alopecia, experienced hair loss after several mesotherapy sessions that had previously been uneventful. Clinical, dermoscopic, and histopathological findings indicated an inflammatory scarring process at the injection sites. One patient showed slight improvement after using minoxidil 5%, while another had a good response to topical Melatonin solution. The study concluded that mesotherapy for androgenetic alopecia might paradoxically induce hair loss and scarring, highlighting the need for proper regulation and monitoring of mesotherapy products used for treating hair loss.
    Discuss this study in the Community →

    Research cited in this study

    2 / 2 results

    Related Community Posts Join

    6 / 333 results

      community New and Interesting HairLoss Studies/Papers/Reviews

      in Treatment  44 upvotes 4 years ago
      Hair loss treatments discussed include Dutasteride with Ketoconazole, tissue engineering strategies, and androgenetic alopecia therapies. Massage doubles follicular retention, improving treatment effectiveness.

      community Bryan Johnson’s Hairloss Regimine

      in Research/Science  26 upvotes 1 year ago
      The post is about Bryan Johnson's hair loss regimen, which includes dutasteride mesotherapy, minoxidil, microneedling, and red laser therapy. The conversation includes discussions about the effectiveness of topical dutasteride and speculation about whether Bryan Johnson has had a hair transplant.
      FCE 28260: A Forgotten 5α-Reductase Inhibitor

      community FCE 28260: A Forgotten 5α-Reductase Inhibitor

      in Research  330 upvotes 2 months ago
      FCE 28260 (PNU 156765), an under-explored 5α-reductase inhibitor, showcases promising results in research by Giudici et al., outperforming well-known treatments like Finasteride in reducing the conversion of testosterone to DHT. Its superior efficacy, demonstrated through lower IC50 values in both natural and human recombinant enzyme studies, suggests it could offer more effective management of DHT-related conditions. Additionally, its lower molecular weight hints at better potential for topical application, potentially offering advantages in treating conditions such as androgenic alopecia. Despite its potential, it has not advanced in development, possibly due to financial limitations, leaving its therapeutic prospects and side effect profile largely unexplored.

      community Exploring Bryan Johnson's Hair Routine In Detail

      in Research/Science  65 upvotes 10 months ago
      Bryan Johnson uses a custom hair loss treatment that includes topical finasteride, minoxidil, azelaic acid, diclofenac, tea tree oil, rosemary oil, ginkgo biloba, biotin, and melatonin, which have shown varying degrees of effectiveness with minimal side effects. He also undergoes PRP and laser therapy, and has tried dutasteride mesotherapy.

    Related Research

    7 / 7 results